|Share price risk||0|
|Health Care Supplies|
Current Price Data+
|Price Movement||$0.02 ( 22.67% )|
- +Security prices are delayed by least 20 minutes and are indicative only.
Unilife Corporation Limited (UNS) is a designer, manufacturer and supplier of innovative injectable drug delivery systems that can enhance and differentiate the injectable drugs, biologics and vaccines, or collectively injectable therapies, of pharmaceutical and biotechnology customers. UNS has a portfolio of proprietary product platforms including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems.
|Year to Jun||NPAT||EPS||EPS chg (%)||PER||DPS||Yield (%)||Franking (%)|
|Company||Mkt Cap||EPS Growth (%)||P/E (%)||Dividend Yield (%)|
|2013 A||2014 F||2015 F||2013 A||2014 F||2015 F||2013 A||2014 F||2015 F|
|Earnings||P/E Ratio||P/B Ratio||P/E Growth|
|Mr Jeffrey Noel Carter||Non-Executive Director||5 Nov 2009|
|Mr William Galle||Non-Executive Director||5 Nov 2009|
|Mr John M Lund||Non-Executive Director||5 Nov 2009|
|Mr Harry Hamill||Non-Executive Director||24 Aug 2015|
|Ms Mary Katherine (Kate) Wold||Non-Executive Director, Non-Executive Chairman||11 May 2010|
|John Ryan||Company Secretary,Senior Vice President, General Counsel,Chief Executive Officer|
|David C Hastings||Senior Vice President and Chief Financial Officer|
|Dennis P Pyers||Senior Vice President and Controller|
|0 (0%)||No substantial shareholder's information disclosed|
Calendar of Events
|08 February 2017||Report (Interim)|
|13 September 2016||Report (Annual)|
|29 August 2016||Report (Prelim)|
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.